Kotronen Anna, Vehkavaara Satu, Seppälä-Lindroos Anneli, Bergholm Robert, Yki-Järvinen Hannele
Dept. of Medicine, Division of Diabetes, Univ. of Helsinki, P.O. Box 700, Rm. C418B, FIN-00029 HUCH, Helsinki, Finland.
Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1709-15. doi: 10.1152/ajpendo.00444.2007. Epub 2007 Sep 25.
A fatty liver is associated with fasting hyperinsulinemia, which could reflect either impaired insulin clearance or hepatic insulin action. We determined the effect of liver fat on insulin clearance and hepatic insulin sensitivity in 80 nondiabetic subjects [age 43 +/- 1 yr, body mass index (BMI) 26.3 +/- 0.5 kg/m(2)]. Insulin clearance and hepatic insulin resistance were measured by the euglycemic hyperinsulinemic (insulin infusion rate 0.3 mU.kg(-1).min(-1) for 240 min) clamp technique combined with the infusion of [3-(3)H]glucose and liver fat by proton magnetic resonance spectroscopy. During hyperinsulinemia, both serum insulin concentrations and increments above basal remained approximately 40% higher (P < 0.0001) in the high (15.0 +/- 1.5%) compared with the low (1.8 +/- 0.2%) liver fat group, independent of age, sex, and BMI. Insulin clearance (ml.kg fat free mass(-1).min(-1)) was inversely related to liver fat content (r = -0.52, P < 0.0001), independent of age, sex, and BMI (r = -0.37, P = 0.001). The variation in insulin clearance due to that in liver fat (range 0-41%) explained on the average 27% of the variation in fasting serum (fS)-insulin concentrations. The contribution of impaired insulin clearance to fS-insulin concentrations increased as a function of liver fat. This implies that indirect indexes of insulin sensitivity, such as homeostatic model assessment, overestimate insulin resistance in subjects with high liver fat content. Liver fat content correlated significantly with fS-insulin concentrations adjusted for insulin clearance (r = 0.43, P < 0.0001) and with directly measured hepatic insulin sensitivity (r = -0.40, P = 0.0002). We conclude that increased liver fat is associated with both impaired insulin clearance and hepatic insulin resistance. Hepatic insulin sensitivity associates with liver fat content, independent of insulin clearance.
脂肪肝与空腹高胰岛素血症相关,这可能反映了胰岛素清除受损或肝脏胰岛素作用受损。我们在80名非糖尿病受试者[年龄43±1岁,体重指数(BMI)26.3±0.5kg/m²]中确定了肝脏脂肪对胰岛素清除和肝脏胰岛素敏感性的影响。通过正常血糖高胰岛素钳夹技术(胰岛素输注速率为0.3mU·kg⁻¹·min⁻¹,持续240分钟)结合[3-(³H)]葡萄糖输注和质子磁共振波谱法测量肝脏脂肪,来测定胰岛素清除和肝脏胰岛素抵抗。在高胰岛素血症期间,与低肝脏脂肪组(1.8±0.2%)相比,高肝脏脂肪组(15.0±1.5%)的血清胰岛素浓度及其高于基础值的增幅均高出约40%(P<0.0001),且不受年龄、性别和BMI的影响。胰岛素清除率(ml·kg去脂体重⁻¹·min⁻¹)与肝脏脂肪含量呈负相关(r=-0.52,P<0.0001),不受年龄、性别和BMI的影响(r=-0.37,P=0.001)。由于肝脏脂肪变化(范围为0-41%)导致的胰岛素清除率变化平均解释了空腹血清(fS)胰岛素浓度变化的27%。胰岛素清除受损对fS胰岛素浓度的贡献随着肝脏脂肪含量增加而增加。这意味着胰岛素敏感性的间接指标,如稳态模型评估,在肝脏脂肪含量高的受试者中高估了胰岛素抵抗。肝脏脂肪含量与校正胰岛素清除率后的fS胰岛素浓度显著相关(r=0.43,P<0.0001),与直接测量的肝脏胰岛素敏感性显著相关(r=-0.40,P=0.0002)。我们得出结论,肝脏脂肪增加与胰岛素清除受损和肝脏胰岛素抵抗均相关。肝脏胰岛素敏感性与肝脏脂肪含量相关,与胰岛素清除无关。